Director, BD&L Forecasting
CSL Innovation(3 months ago)
About this role
The role leads BD&L forecasting and portfolio analytics for Cardiovascular & Renal and Transplant & Immunology therapy areas, representing the Insights & Analytics forecasting function within commercial due diligence. It is responsible for shaping strategic direction and optimizing the pharmaceutical portfolio through data-driven revenue forecasting and analytics. The position is part of the Global I&A team at CSL Behring and partners across functions to inform business development and investment decisions.
Required Skills
- Forecasting
- Analytics
- Commercial Forecasting
- Market Research
- Competitive Analysis
- Time Series
- Patient Modeling
- Monte Carlo
- Tableau
- QlikSense
+4 more
Qualifications
- Bachelor's Degree (Science or Business)
- Postgraduate Degree (Preferred)
About CSL Innovation
csl.comCSL is a leading global biotechnology company dedicated to creating lifesaving medicines. With a portfolio that includes therapies for rare diseases, immune deficiencies, and vaccines for influenza, CSL's mission is rooted in innovation and public health. The organization comprises three distinct businesses: CSL Behring, focused on plasma-derived therapies; CSL Seqirus, specializing in influenza vaccines; and CSL Vifor, addressing iron deficiency and nephrology. Since its founding in 1916, CSL has been committed to ensuring access to essential treatments for patients in over 100 countries.
View more jobs at CSL Innovation →Apply instantly with AI
Let ApplyBlast auto-apply to jobs like this for you. Save hours on applications and land your dream job faster.
More jobs at CSL Innovation
Similar Jobs
Associate Director/Lead, US Solid Tumor Forecasting, Global Oncology
Takeda Pharmaceutical Company(5 months ago)
Senior Manager of Global Forecasting, Obesity
Amgen(1 month ago)
Manager- Strategic Forecasting
MSD(18 days ago)
Forecasting Analyst
KLA(2 months ago)
CIO Strategy - Quantitative Analyst
Barclays(27 days ago)
CD&A - Forecasting Senior Manager, Rare Disease
Amgen(2 months ago)